We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Microfiber Pad Helps Collect Uncontaminated Urine Samples

By LabMedica International staff writers
Posted on 27 Jan 2016
Print article
Image: The UCap microfiber urine collection pad (Photo courtesy of BioDesign/HUJI).
Image: The UCap microfiber urine collection pad (Photo courtesy of BioDesign/HUJI).
A new noninvasive microfiber pad draws urine samples in seconds, preventing cross-contamination during collection.

Developed by researchers of the BioDesign team at the Hebrew University (HUJI; Jerusalem, Israel) and Hadassah Medical Center (Jerusalem, Israel), the UCap microfiber urine collection pad contains bundles of hollow glass microfibers that quickly draw urine via capillary action from absorptive pads in just seconds. The remainder of the urine is absorbed by a polymer matrix, thus preventing cross-contamination of the urine sample by contact with the patient’s skin or fecal matter.

The low-cost but highly effective solution can save time and money in the collection of sterile samples from patients especially prone to contract a urinary tract infection (UTI), including infants and bed-ridden hospitalized patients. While sterile urine samples can be readily collected in adults using simple plastic cups, urine collections in infants and hospitalized populations relies on adhesive plastic bags or on invasive catheters.

“Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically, increasing the risk of developing antibiotic resistant bacteria,” said Amir Orlev, MD, who was part of the multidisciplinary BioDesign team set out to solve the problem under a medical innovation program.

“More than 11 million urine tests are carried out each year in infants and elderly patients. This presents a market of USD 100 million annually in the United States alone,” said BioDesign team member MBA student Itai Monnickendam. “Our low-cost urine collection pad has the potential to reduce pain and complications for millions of people and save time and expenditure for the healthcare system.”

Related Links:

Hebrew University of Jerusalem
Hadassah Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.